Kyme Pierre 4
4 · Armata Pharmaceuticals, Inc. · Filed Apr 25, 2025
Insider Transaction Report
Form 4
Kyme Pierre
Chief Business Officer
Transactions
- Tax Payment
Common Stock
2025-03-14$1.95/sh−1,027$2,003→ 10,491 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Company to satisfy its income tax and withholding remittance obligations in connection with the net settlement of restricted stock units.